FRIDAY, Nov. 1, 2024 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer...

FRIDAY, Nov. 1, 2024 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer...

Scientists from Yale and other institutions have discovered that tirzepatide, a drug approved to treat type 2 diabetes, may also be highly effective...

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A study published in...

THURSDAY, Oct. 24, 2024 -- Malnutrition is more likely among patients undergoing multiple orthopedic surgeries, according to a study presented at the...

FRIDAY, Oct. 25, 2024 -- Delabeling patients with syphilis who believe they are allergic to penicillin is safe, according to a study presented at the...

The rise in type 2 diabetes has become a significant public health concern in recent years. This form of diabetes happens when the body struggles to...

WEDNESDAY, Oct. 30, 2024 -- Machine learning can help identify individuals with diabetes at high risk for diabetic cardiomyopathy (DbCM), according to...

MONDAY, Oct. 28, 2024 -- For patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer...